In Silico Assessment of Drug Metabolism and Toxicity

Information

  • Research Project
  • 6692289
  • ApplicationId
    6692289
  • Core Project Number
    R43GM069124
  • Full Project Number
    1R43GM069124-01
  • Serial Number
    69124
  • FOA Number
  • Sub Project Id
  • Project Start Date
    7/15/2003 - 21 years ago
  • Project End Date
    1/14/2004 - 21 years ago
  • Program Officer Name
    WOLPERT, MARY K
  • Budget Start Date
    7/15/2003 - 21 years ago
  • Budget End Date
    1/14/2004 - 21 years ago
  • Fiscal Year
    2003
  • Support Year
    1
  • Suffix
  • Award Notice Date
    7/14/2003 - 21 years ago
Organizations

In Silico Assessment of Drug Metabolism and Toxicity

DESCRIPTION (provided by applicant): In this application we propose to build a new in silico platform (dubbed MetaDrugTM)for predicting metabolism and possible toxic effects of novel drug candidates. The platform will integrate advanced QSAR and expert system approaches with our extensive database on human pathways and our software for reconstruction and visualization of metabolic and cell signaling networks. First we develop capabilities to analyze compound's structural and physicochemical similarity to known substrates of all human Cytochrome P450 superfamily enzymes and predict whether and how it may enter human metabolism. Using our existing reaction database we will identify specific types of biochemical transformations catalyzed by human cytochromes (model reactions) and formulate sets of most essential molecular features and rules for every such type. We will develop a special algorithm capable to recognize such rules and apply them (in conjunction with advanced QSAR methods) to identify the likely metabolites of any novel xenobiotic compound. Second we will adapt our existing network-building software for predicting the metabolic fates of xenobiotics. We will develop a novel tool that generates sets of putative reactions based on predicted substrate potential and model reactions. The existing network building software will handle these newly introduced reactions and visualize them as interactive maps. Third we develop an interface that aligns predicted networks with our functional maps of human biochemistry and cell signaling. The user will be able to view interactions between xeno- and endobiotics metabolism pathways in different tissues, analyze them visually on functional maps, access related information on associated diseases, genetic polymorphisms, etc. When completed, this platform will be applicable in predicting the toxicity of novel drug candidates, evaluating the risks associated with environmental pollutants and monitoring human exposure to pathogens and toxins.

IC Name
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
  • Activity
    R43
  • Administering IC
    GM
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    100000
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    821
  • Ed Inst. Type
  • Funding ICs
    NIGMS:100000\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    GENEGO, INC.
  • Organization Department
  • Organization DUNS
    113429489
  • Organization City
    ST. JOSEPH
  • Organization State
    MI
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    49085
  • Organization District
    UNITED STATES